Sagimet Biosciences
SGMT • NASDAQ
Sagimet Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David A. Happel, with a market cap of $183.8M.
Market Cap$183.8M
Employees10.0
CEODavid A. Happel
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
SGM
Sagimet Biosciences FAQ
Common questions about Sagimet Biosciences
Sagimet Biosciences is scheduled to report earnings for Q1 2026 on May 7, 2026.
Sagimet Biosciences has approximately 10 employees.